Commercialisation director joins Edinburgh BioQuarter

Life sciences entrepreneur Michael Capaldi joins Scotland\'s flagship project

Michael Capaldi, scientist and life sciences entrepreneur, has been named as director of commercialisation for the Edinburgh BioQuarter – Scotland’s flagship project for the life sciences sector.

Capaldi will lead a team of up to 15 people to progress a £12m commercialisation project that will bridge the gap between industry and research.

Capaldi has more than 26 years’ experience in the pharmaceutical and life sciences industries within the UK, Europe and the US.

You may also like

Research & Development

University of Edinburgh to collaborate with Galapagos on cancer therapies

Two-year partnership with plans to extend
Research & Development

AlzeCure Pharma publishes response letter clarifying Alzstatin’s distinct mechanism in Alzheimer’s treatment

AlzeCure Pharma and leading academic collaborators have published a response in JPET addressing recent commentary on Alzstatin’s γ-secretase modulation data, reaffirming the promise of lead candidate ACD680 in Alzheimer’s therapy
Drug Delivery

Optimized fittings for microfluidic systems

Miniature flat-bottom ports combine convenience and performance for precise fluid control
Regulatory

Piramal Pharma Solutions awards Riverview and Digwal for patient centricity

Two sites recognized for innovative initiatives that put patients first
Manufacturing

What to expect from a regulatory inspection

NSF’s expert guide outlines key expectations, common pitfalls and strategies for lasting inspection readiness
Manufacturing

FDA US agent services backed by regulatory expertise

Helping medical device companies achieve smooth US market entry
Manufacturing

IMA showcases innovation in processing and packaging at CPHI Frankfurt 2025

From gloveless filling to continuous manufacturing, IMA presents next-generation pharma and medtech solutions
Subscribe now